{
    "nct_id": "NCT06209567",
    "official_title": "An Investigator-Initiated Study to Evaluate PSMA Expression in Patients With High-Grade Gliomas or Brain Metastases With 68Ga-PSMA-11 PET",
    "inclusion_criteria": "* Ability to understand and the willingness to sign (or their legally acceptable representative (LAR) must sign) a written informed consent document\n* Adults ≥ 18 years old\n* Suspicion for or histologically or cytologically confirmed and previously treated HGG or brain metastases from a primary extracranial malignancy\n* Lesion size ≥ 1 cm (for the lesion to be biopsied)\n* ECOG performance status ≤ 2 (Karnofsky ≥ 60%)\n* Planned to undergo biopsy/resection of brain lesion\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Inability to undergo a PET scan (e.g., claustrophobia or noncompatible implant in case PET/MR is performed)\n* Pregnant or nursing female. All women of childbearing potential must have a documented negative serum or urine pregnancy test <1 week before study.\n* Uncontrolled, intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiacarrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements.\n* Patients with severe allergy to both iodinated and gadolinium contrast.",
    "miscellaneous_criteria": ""
}